(MMS) Maximus - Ratings and Ratios
Healthcare, Eligibility, Enrollment, Assessment, Services
MMS EPS (Earnings per Share)
MMS Revenue
Description: MMS Maximus
Maximus Inc (NYSE:MMS) is a leading provider of government services worldwide, operating through three distinct segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The companys diverse portfolio of services includes business process services, clinical services, technology solutions, and employment services, catering to federal health and human services programs, international governments, and other public sector entities.
From a financial perspective, Maximus Inc has a market capitalization of approximately $4 billion, with a price-to-earnings ratio of 14.30 and a forward P/E of 18.25, indicating a relatively stable valuation. The companys return on equity stands at 17.20%, suggesting a decent level of profitability. To further evaluate the companys performance, we can examine key performance indicators (KPIs) such as revenue growth, operating margins, and contract backlog. For instance, a high revenue growth rate and expanding operating margins could indicate a strong competitive position and efficient operations.
To gain a deeper understanding of Maximus Incs financial health, we can analyze its revenue diversification across different segments and geographies. The companys presence in multiple markets, including the U.S. federal government and international governments, may provide a degree of stability and reduce dependence on a single revenue stream. Additionally, we can assess the companys cash flow generation, debt-to-equity ratio, and interest coverage ratio to gauge its financial flexibility and ability to invest in growth initiatives.
From an operational perspective, Maximus Incs ability to deliver complex government services and technology solutions is a key driver of its success. The companys expertise in areas such as application development, cybersecurity, and advanced analytics can help drive efficiency and innovation in the public sector. By examining KPIs such as customer satisfaction ratings, contract win rates, and employee utilization rates, we can gain insights into the companys operational effectiveness and its ability to deliver value to clients.
MMS Stock Overview
| Market Cap in USD | 4,990m |
| Sub-Industry | Data Processing & Outsourced Services |
| IPO / Inception | 1997-06-12 |
MMS Stock Ratings
| Growth Rating | 27.5% |
| Fundamental | 71.5% |
| Dividend Rating | 48.2% |
| Return 12m vs S&P 500 | -12.7% |
| Analyst Rating | 4.0 of 5 |
MMS Dividends
| Dividend Yield 12m | 1.48% |
| Yield on Cost 5y | 1.79% |
| Annual Growth 5y | 1.39% |
| Payout Consistency | 91.9% |
| Payout Ratio | 16.6% |
MMS Growth Ratios
| Growth Correlation 3m | 95.4% |
| Growth Correlation 12m | -27.2% |
| Growth Correlation 5y | 18.8% |
| CAGR 5y | 16.31% |
| CAGR/Max DD 3y | 0.54 |
| CAGR/Mean DD 3y | 3.03 |
| Sharpe Ratio 12m | 0.73 |
| Alpha | -15.75 |
| Beta | 0.992 |
| Volatility | 25.10% |
| Current Volume | 459.9k |
| Average Volume 20d | 551.7k |
| Stop Loss | 86.8 (-3.1%) |
| Signal | -0.49 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (316.2m TTM) > 0 and > 6% of Revenue (6% = 325.7m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -0.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 16.56% (prev 7.59%; Δ 8.97pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.01 (>3.0%) and CFO -56.2m <= Net Income 316.2m (YES >=105%, WARN >=100%) |
| Net Debt (1.72b) to EBITDA (648.1m) ratio: 2.66 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (57.0m) change vs 12m ago -7.16% (target <= -2.0% for YES) |
| Gross Margin 23.98% (prev 23.22%; Δ 0.75pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 128.3% (prev 131.3%; Δ -2.96pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.35 (EBITDA TTM 648.1m / Interest Expense TTM 81.7m) >= 6 (WARN >= 3) |
Altman Z'' 3.68
| (A) 0.20 = (Total Current Assets 1.61b - Total Current Liabilities 706.2m) / Total Assets 4.46b |
| (B) 0.26 = Retained Earnings (Balance) 1.16b / Total Assets 4.46b |
| (C) 0.12 = EBIT TTM 518.7m / Avg Total Assets 4.23b |
| (D) 0.66 = Book Value of Equity 1.77b / Total Liabilities 2.69b |
| Total Rating: 3.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.52
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 6.05% = 3.03 |
| 3. FCF Margin 7.39% = 1.85 |
| 4. Debt/Equity 0.96 = 2.06 |
| 5. Debt/Ebitda 2.62 = -1.17 |
| 6. ROIC - WACC 4.96% = 6.20 |
| 7. RoE 18.25% = 1.52 |
| 8. Rev. Trend 86.98% = 4.35 |
| 9. Rev. CAGR 5.07% = 0.63 |
| 10. EPS Trend 62.15% = 1.55 |
| 11. EPS CAGR 19.99% = 2.00 |
What is the price of MMS shares?
Over the past week, the price has changed by +1.36%, over one month by +6.35%, over three months by +29.39% and over the past year by +3.20%.
Is Maximus a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MMS is around 84.00 USD . This means that MMS is currently overvalued and has a potential downside of -6.19%.
Is MMS a buy, sell or hold?
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 105 | 17.3% |
| Analysts Target Price | 105 | 17.3% |
| ValueRay Target Price | 92.8 | 3.6% |
Last update: 2025-09-05 04:52
MMS Fundamental Data Overview
CCE Cash And Equivalents = 59.8m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.4517
P/E Forward = 18.2482
P/S = 0.9191
P/B = 2.8142
P/EG = 2.0716
Beta = 0.602
Revenue TTM = 5.43b USD
EBIT TTM = 518.7m USD
EBITDA TTM = 648.1m USD
Long Term Debt = 1.61b USD (from longTermDebt, last quarter)
Short Term Debt = 88.1m USD (from shortTermDebt, last quarter)
Debt = 1.70b USD (Calculated: Short Term 88.1m + Long Term 1.61b)
Net Debt = 1.72b USD (from netDebt column, last quarter)
Enterprise Value = 6.63b USD (4.99b + Debt 1.70b - CCE 59.8m)
Interest Coverage Ratio = 6.35 (Ebit TTM 518.7m / Interest Expense TTM 81.7m)
FCF Yield = 6.05% (FCF TTM 401.1m / Enterprise Value 6.63b)
FCF Margin = 7.39% (FCF TTM 401.1m / Revenue TTM 5.43b)
Net Margin = 5.83% (Net Income TTM 316.2m / Revenue TTM 5.43b)
Gross Margin = 23.98% ((Revenue TTM 5.43b - Cost of Revenue TTM 4.13b) / Revenue TTM)
Tobins Q-Ratio = 3.74 (Enterprise Value 6.63b / Book Value Of Equity 1.77b)
Interest Expense / Debt = 1.34% (Interest Expense 22.7m / Debt 1.70b)
Taxrate = 24.50% (99.6m / 406.5m)
NOPAT = 391.6m (EBIT 518.7m * (1 - 24.50%))
Current Ratio = 2.27 (Total Current Assets 1.61b / Total Current Liabilities 706.2m)
Debt / Equity = 0.96 (Debt 1.70b / last Quarter total Stockholder Equity 1.77b)
Debt / EBITDA = 2.62 (Net Debt 1.72b / EBITDA 648.1m)
Debt / FCF = 4.23 (Debt 1.70b / FCF TTM 401.1m)
Total Stockholder Equity = 1.73b (last 4 quarters mean)
RoA = 7.09% (Net Income 316.2m, Total Assets 4.46b )
RoE = 18.25% (Net Income TTM 316.2m / Total Stockholder Equity 1.73b)
RoCE = 15.52% (Ebit 518.7m / (Equity 1.73b + L.T.Debt 1.61b))
RoIC = 12.43% (NOPAT 391.6m / Invested Capital 3.15b)
WACC = 7.47% (E(4.99b)/V(6.69b) * Re(9.67%)) + (D(1.70b)/V(6.69b) * Rd(1.34%) * (1-Tc(0.25)))
Shares Correlation 3-Years: -27.27 | Cagr: -0.66%
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 69.76% ; FCFE base≈386.2m ; Y1≈333.0m ; Y5≈262.5m
Fair Price DCF = 65.00 (DCF Value 3.66b / Shares Outstanding 56.3m; 5y FCF grow -16.81% → 3.0% )
Revenue Correlation: 86.98 | Revenue CAGR: 5.07%
Rev Growth-of-Growth: -3.70
EPS Correlation: 62.15 | EPS CAGR: 19.99%
EPS Growth-of-Growth: -13.39
Additional Sources for MMS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle